FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2920912058> ?p ?o ?g. }

• W2920912058 endingPage "72" @default.
• W2920912058 startingPage "63" @default.
• W2920912058 abstract "ABSTRACT Background The use of haemodiafiltration (HDF) for the management of patients with end‐stage kidney failure is increasing worldwide. Factors associated with HDF use have not been studied and may vary in different countries and jurisdictions. The aim of this study was to document the pattern of increase and variability in uptake of HDF in Australia and New Zealand, and to describe patient‐ and centre‐related factors associated with its use. Methods Using the Australian and New Zealand Dialysis and Transplant Registry, all incident patients commencing haemodialysis (HD) between 2000 and 2014 were included. The primary outcome was HDF commencement over time, which was evaluated using multivariable logistic regression stratified by country. Results Of 27 433 patients starting HD, 3339 (14.4%) of 23 194 patients in Australia and 810 (19.1%) of 4239 in New Zealand received HDF. HDF uptake increased over time in both countries but was more rapid in New Zealand than Australia. In Australia, HDF use was more likely in males (odds ratio (OR) 1.13, 95% confidence interval (CI) = 1.03–1.24, P = 0.009) and less likely with older age (reference <40 years; 40–54 years OR = 0.85; 95% CI = 0.72–0.99; 55–69 years OR = 0.79; 95% CI = 0.67–0.91; >70 years OR = 0.48; 95% CI = 0.41–0.56); higher body mass index (body mass index (BMI) < 18.5 kg/m 2 OR = 0.62; 95% CI = 0.46–0.84; 18.5–29.9 kg/m 2 reference; >30 kg/m 2 OR = 1.46; 95% CI = 1.33–1.61), chronic lung disease (OR = 0.84; 95% CI = 0.76–0.94; P < 0.001), cerebrovascular disease (OR = 0.76; 95% CI = 0.67–0.85; P < 0.001) and peripheral vascular disease (OR = 0.77; 95% CI = 0.70–0.85; P < 0.001). No association was identified with race. In New Zealand, HDF use was more likely in Maori and Pacific Islanders (OR = 1.32; 95% CI = 1.05–1.66) and Asians (OR = 1.75; 95% CI = 1.15–2.68) compared to Caucasians, and less likely in males (OR = 0.76; 95% CI = 0.62–0.94; P = 0.01). No association was identified with BMI or co‐morbidities. In both countries, centres with a higher ratio of HD to peritoneal dialysis (PD) were more likely to prescribe HDF. Larger Australian centres were more likely to prescribe HDF (36–147 new patients/year OR = 26.75, 95% CI = 18.54–38.59; 17–35/year OR = 7.51, 95% CI = 5.35–10.55; 7–16/year OR = 3.00; 95% CI = 2.19–4.13; ≤6/year reference). Conclusion Haemodiafiltration uptake is increasing, variable and associated with both patient and centre characteristics. Centre characteristics not explicitly captured elsewhere explained 36% of variability in HDF uptake in Australia and 48% in New Zealand." @default.
• W2920912058 created "2019-03-22" @default.
• W2920912058 creator A5012365523 @default.
• W2920912058 creator A5012763174 @default.
• W2920912058 creator A5017481619 @default.
• W2920912058 creator A5030014445 @default.
• W2920912058 creator A5032373442 @default.
• W2920912058 creator A5039690611 @default.
• W2920912058 creator A5039834479 @default.
• W2920912058 creator A5041130177 @default.
• W2920912058 creator A5043394711 @default.
• W2920912058 creator A5043927307 @default.
• W2920912058 creator A5053547123 @default.
• W2920912058 creator A5058991365 @default.
• W2920912058 date "2019-05-02" @default.
• W2920912058 modified "2023-09-30" @default.
• W2920912058 title "Effect of centre‐ and patient‐related factors on uptake of haemodiafiltration in Australia and New Zealand: A cohort study using ANZDATA" @default.
• W2920912058 cites W1531710611 @default.
• W2920912058 cites W1561574889 @default.
• W2920912058 cites W2009019020 @default.
• W2920912058 cites W2031619699 @default.
• W2920912058 cites W2033007568 @default.
• W2920912058 cites W2037725949 @default.
• W2920912058 cites W2043907454 @default.
• W2920912058 cites W2089341196 @default.
• W2920912058 cites W2091874987 @default.
• W2920912058 cites W2113529096 @default.
• W2920912058 cites W2125850135 @default.
• W2920912058 cites W2136929928 @default.
• W2920912058 cites W2148646288 @default.
• W2920912058 cites W2150175482 @default.
• W2920912058 cites W2167215662 @default.
• W2920912058 cites W2177264682 @default.
• W2920912058 cites W2219350253 @default.
• W2920912058 cites W2224610173 @default.
• W2920912058 cites W2565784532 @default.
• W2920912058 cites W2797428003 @default.
• W2920912058 doi "https://doi.org/10.1111/nep.13574" @default.
• W2920912058 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30838737" @default.
• W2920912058 hasPublicationYear "2019" @default.
• W2920912058 type Work @default.
• W2920912058 sameAs 2920912058 @default.
• W2920912058 citedByCount "5" @default.
• W2920912058 countsByYear W29209120582020 @default.
• W2920912058 countsByYear W29209120582021 @default.
• W2920912058 countsByYear W29209120582022 @default.
• W2920912058 crossrefType "journal-article" @default.
• W2920912058 hasAuthorship W2920912058A5012365523 @default.
• W2920912058 hasAuthorship W2920912058A5012763174 @default.
• W2920912058 hasAuthorship W2920912058A5017481619 @default.
• W2920912058 hasAuthorship W2920912058A5030014445 @default.
• W2920912058 hasAuthorship W2920912058A5032373442 @default.
• W2920912058 hasAuthorship W2920912058A5039690611 @default.
• W2920912058 hasAuthorship W2920912058A5039834479 @default.
• W2920912058 hasAuthorship W2920912058A5041130177 @default.
• W2920912058 hasAuthorship W2920912058A5043394711 @default.
• W2920912058 hasAuthorship W2920912058A5043927307 @default.
• W2920912058 hasAuthorship W2920912058A5053547123 @default.
• W2920912058 hasAuthorship W2920912058A5058991365 @default.
• W2920912058 hasConcept C126322002 @default.
• W2920912058 hasConcept C144024400 @default.
• W2920912058 hasConcept C149923435 @default.
• W2920912058 hasConcept C151956035 @default.
• W2920912058 hasConcept C156957248 @default.
• W2920912058 hasConcept C2779978075 @default.
• W2920912058 hasConcept C2780221984 @default.
• W2920912058 hasConcept C44249647 @default.
• W2920912058 hasConcept C71924100 @default.
• W2920912058 hasConcept C72563966 @default.
• W2920912058 hasConceptScore W2920912058C126322002 @default.
• W2920912058 hasConceptScore W2920912058C144024400 @default.
• W2920912058 hasConceptScore W2920912058C149923435 @default.
• W2920912058 hasConceptScore W2920912058C151956035 @default.
• W2920912058 hasConceptScore W2920912058C156957248 @default.
• W2920912058 hasConceptScore W2920912058C2779978075 @default.
• W2920912058 hasConceptScore W2920912058C2780221984 @default.
• W2920912058 hasConceptScore W2920912058C44249647 @default.
• W2920912058 hasConceptScore W2920912058C71924100 @default.
• W2920912058 hasConceptScore W2920912058C72563966 @default.
• W2920912058 hasFunder F4320320415 @default.
• W2920912058 hasFunder F4320322836 @default.
• W2920912058 hasFunder F4320334705 @default.
• W2920912058 hasIssue "1" @default.
• W2920912058 hasLocation W29209120581 @default.
• W2920912058 hasLocation W29209120582 @default.
• W2920912058 hasOpenAccess W2920912058 @default.
• W2920912058 hasPrimaryLocation W29209120581 @default.
• W2920912058 hasRelatedWork W1925385967 @default.
• W2920912058 hasRelatedWork W2037611947 @default.
• W2920912058 hasRelatedWork W2115595203 @default.
• W2920912058 hasRelatedWork W2321021262 @default.
• W2920912058 hasRelatedWork W2335988042 @default.
• W2920912058 hasRelatedWork W2468724271 @default.
• W2920912058 hasRelatedWork W2971695752 @default.
• W2920912058 hasRelatedWork W3164486645 @default.
• W2920912058 hasRelatedWork W4313252199 @default.
• W2920912058 hasRelatedWork W4322739880 @default.
• W2920912058 hasVolume "25" @default.

• next